178 related articles for article (PubMed ID: 31118804)
1. Disulfiram inhibits epithelial-mesenchymal transition through TGFβ-ERK-Snail pathway independently of Smad4 to decrease oral squamous cell carcinoma metastasis.
Bu W; Wang Z; Meng L; Li X; Liu X; Chen Y; Xin Y; Li B; Sun H
Cancer Manag Res; 2019; 11():3887-3898. PubMed ID: 31118804
[No Abstract] [Full Text] [Related]
2. [Effect of disulfiram on epithelial-mesenchymal transformation of oral squamous cell carcinoma cells].
Wang XM; Jiang Y
Shanghai Kou Qiang Yi Xue; 2020 Apr; 29(2):138-145. PubMed ID: 32626875
[TBL] [Abstract][Full Text] [Related]
3. Disulfiram combined with copper inhibits metastasis and epithelial-mesenchymal transition in hepatocellular carcinoma through the NF-κB and TGF-β pathways.
Li Y; Wang LH; Zhang HT; Wang YT; Liu S; Zhou WL; Yuan XZ; Li TY; Wu CF; Yang JY
J Cell Mol Med; 2018 Jan; 22(1):439-451. PubMed ID: 29148232
[TBL] [Abstract][Full Text] [Related]
4. Disulfiram inhibits TGF-β-induced epithelial-mesenchymal transition and stem-like features in breast cancer via ERK/NF-κB/Snail pathway.
Han D; Wu G; Chang C; Zhu F; Xiao Y; Li Q; Zhang T; Zhang L
Oncotarget; 2015 Dec; 6(38):40907-19. PubMed ID: 26517513
[TBL] [Abstract][Full Text] [Related]
5. Role of SIRT1 in regulation of epithelial-to-mesenchymal transition in oral squamous cell carcinoma metastasis.
Chen IC; Chiang WF; Huang HH; Chen PF; Shen YY; Chiang HC
Mol Cancer; 2014 Nov; 13():254. PubMed ID: 25424420
[TBL] [Abstract][Full Text] [Related]
6. Disulfiram inhibits epithelial-mesenchymal transition through TGFβ-ERK-Snail pathway independently of Smad4 to decrease oral squamous cell carcinoma metastasis [Corrigendum].
Bu W; Wang Z; Meng L; Li X; Liu X; Chen Y; Xin Y; Li B; Sun H
Cancer Manag Res; 2019; 11():4617. PubMed ID: 31191022
[No Abstract] [Full Text] [Related]
7. Erratum: Disulfiram Inhibits Epithelial-Mesenchymal Transition Through TGF
Cancer Manag Res; 2021; 13():8647-8650. PubMed ID: 34858055
[TBL] [Abstract][Full Text] [Related]
8. Nrf2/HO-1 Alleviates Disulfiram/Copper-Induced Ferroptosis in Oral Squamous Cell Carcinoma.
Zhao Y; Zhu S
Biochem Genet; 2024 Feb; 62(1):144-155. PubMed ID: 37286868
[TBL] [Abstract][Full Text] [Related]
9. KLF7 overexpression in human oral squamous cell carcinoma promotes migration and epithelial-mesenchymal transition.
Ding X; Wang X; Gong Y; Ruan H; Sun Y; Yu Y
Oncol Lett; 2017 Apr; 13(4):2281-2289. PubMed ID: 28454392
[TBL] [Abstract][Full Text] [Related]
10. miR-130a-3p regulated TGF-β1-induced epithelial-mesenchymal transition depends on SMAD4 in EC-1 cells.
Tian X; Fei Q; Du M; Zhu H; Ye J; Qian L; Lu Z; Zhang W; Wang Y; Peng F; Chen J; Liu B; Li Q; He X; Yin L
Cancer Med; 2019 Mar; 8(3):1197-1208. PubMed ID: 30741461
[TBL] [Abstract][Full Text] [Related]
11. Notch signalling induces epithelial‑mesenchymal transition to promote metastasis in oral squamous cell carcinoma.
Zhang J; Zheng G; Zhou L; Li P; Yun M; Shi Q; Wang T; Wu X
Int J Mol Med; 2018 Oct; 42(4):2276-2284. PubMed ID: 30015856
[TBL] [Abstract][Full Text] [Related]
12. Disulfiram suppresses epithelial-mesenchymal transition (EMT), migration and invasion in cervical cancer through the HSP90A/NDRG1 pathway.
Zheng P; Wu Y; Wang Y; Hu F
Cell Signal; 2023 Sep; 109():110771. PubMed ID: 37329997
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of Akt activity induces the mesenchymal-to-epithelial reverting transition with restoring E-cadherin expression in KB and KOSCC-25B oral squamous cell carcinoma cells.
Hong KO; Kim JH; Hong JS; Yoon HJ; Lee JI; Hong SP; Hong SD
J Exp Clin Cancer Res; 2009 Feb; 28(1):28. PubMed ID: 19243631
[TBL] [Abstract][Full Text] [Related]
14. miR-146a promotes proliferation, invasion, and epithelial-to-mesenchymal transition in oral squamous carcinoma cells.
Wang F; Ye LJ; Wang FJ; Liu HF; Wang XL
Environ Toxicol; 2020 Oct; 35(10):1050-1057. PubMed ID: 32469461
[TBL] [Abstract][Full Text] [Related]
15. Neuropilin-1 promotes epithelial-to-mesenchymal transition by stimulating nuclear factor-kappa B and is associated with poor prognosis in human oral squamous cell carcinoma.
Chu W; Song X; Yang X; Ma L; Zhu J; He M; Wang Z; Wu Y
PLoS One; 2014; 9(7):e101931. PubMed ID: 24999732
[TBL] [Abstract][Full Text] [Related]
16. Transcutaneous carbon dioxide suppresses epithelial-mesenchymal transition in oral squamous cell carcinoma.
Iwata E; Hasegawa T; Takeda D; Ueha T; Kawamoto T; Akisue T; Sakai Y; Komori T
Int J Oncol; 2016 Apr; 48(4):1493-8. PubMed ID: 26846904
[TBL] [Abstract][Full Text] [Related]
17. Bovine lactoferrin reverses programming of epithelial-to-mesenchymal transition to mesenchymal-to-epithelial transition in oral squamous cell carcinoma.
Chea C; Miyauchi M; Inubushi T; Okamoto K; Haing S; Nguyen PT; Imanaka H; Takata T
Biochem Biophys Res Commun; 2018 Dec; 507(1-4):142-147. PubMed ID: 30415774
[TBL] [Abstract][Full Text] [Related]
18. Differential roles of kallikrein-related peptidase 6 in malignant transformation and ΔNp63β-mediated epithelial-mesenchymal transition of oral squamous cell carcinoma.
Kaneko N; Kawano S; Yasuda K; Hashiguchi Y; Sakamoto T; Matsubara R; Goto Y; Jinno T; Maruse Y; Morioka M; Hattori T; Tanaka S; Tanaka H; Kiyoshima T; Nakamura S
Oral Oncol; 2017 Dec; 75():148-157. PubMed ID: 29224812
[TBL] [Abstract][Full Text] [Related]
19. Loss of VHL expression contributes to epithelial-mesenchymal transition in oral squamous cell carcinoma.
Zhang S; Zhou X; Wang B; Zhang K; Liu S; Yue K; Zhang L; Wang X
Oral Oncol; 2014 Sep; 50(9):809-17. PubMed ID: 24998140
[TBL] [Abstract][Full Text] [Related]
20. Metformin inhibits epithelial-mesenchymal transition of oral squamous cell carcinoma via the mTOR/HIF-1α/PKM2/STAT3 pathway.
Yin W; Liu Y; Liu X; Ma X; Sun B; Yu Z
Oncol Lett; 2021 Jan; 21(1):31. PubMed ID: 33262823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]